Literature DB >> 9465094

Genes in the pX region of human T cell leukemia virus I influence Vav phosphorylation in T cells.

W Mahana1, T M Zhao, R Teller, M A Robinson, T J Kindt.   

Abstract

Human T cell leukemia virus I (HTLV-I) causes acute leukemic disease in a low percentage of infected individuals through obscure mechanisms. Our studies compare two rabbit HTLV-I-infected T cell lines: one, RH/K34, causes lethal experimental leukemia and the other, RH/K30, mediates asymptomatic infection. We show herein that the product of the protooncogene vav is constitutively Tyr-phosphorylated in RH/K34 but not in RH/K30. A role for the retrovirus in phosphorylation of Vav was assigned by transfection experiments with molecular clones of HTLV-I derived from the two lines. The HTLV-I molecular clone from RH/K30, but not that from RH/K34, down-regulates Vav phosphorylation in a Herpesvirus ateles-transformed T cell line. Use of recombinant virus clones revealed that a pX region sequence differing by two nucleotides between the two clones mediates this down-regulation. Because Vav is involved in T cell signaling and Vav phosphorylation occurs upon activation of T cells, control of the activation state of Vav by viral proteins may relate to the leukemogenic potential of certain HTLV-I-infected cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9465094      PMCID: PMC19190          DOI: 10.1073/pnas.95.4.1782

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Infectivity of chimeric human T-cell leukemia virus type I molecular clones assessed by naked DNA inoculation.

Authors:  T M Zhao; M A Robinson; F S Bowers; T J Kindt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product.

Authors:  M Deckert; S Tartare-Deckert; C Couture; T Mustelin; A Altman
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

3.  Cutaneous manifestations of human T cell leukemia virus type I infection in an experimental model.

Authors:  R M Simpson; M Leno; B S Hubbard; T J Kindt
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

4.  Does Vav bind to F-actin through a CH domain?

Authors:  J Castresana; M Saraste
Journal:  FEBS Lett       Date:  1995-10-30       Impact factor: 4.124

Review 5.  Human T lymphotropic virus type I in arthropathy and autoimmune disorders.

Authors:  K Nishioka; T Sumida; T Hasunuma
Journal:  Arthritis Rheum       Date:  1996-08

6.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.

Authors:  P Crespo; K E Schuebel; A A Ostrom; J S Gutkind; X R Bustelo
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

7.  The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface.

Authors:  J C Mulloy; R W Crownley; J Fullen; W J Leonard; G Franchini
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Molecular analysis of Ras activation by tyrosine phosphorylated Vav.

Authors:  E Gulbins; K Schlottmann; B Brenner; F Lang; K M Coggeshall
Journal:  Biochem Biophys Res Commun       Date:  1995-12-26       Impact factor: 3.575

9.  Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.

Authors:  R M Simpson; T M Zhao; B S Hubbard; S Sawasdikosol; T J Kindt
Journal:  Lab Invest       Date:  1996-03       Impact factor: 5.662

10.  Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells.

Authors:  X Xu; S H Kang; O Heidenreich; M Okerholm; J J O'Shea; M I Nerenberg
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more
  8 in total

1.  Design of versatile biochemical switches that respond to amplitude, duration, and spatial cues.

Authors:  Azi Lipshtat; Gomathi Jayaraman; John Cijiang He; Ravi Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

Review 2.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

3.  Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.

Authors:  J T Bartoe; B Albrecht; N D Collins; M D Robek; L Ratner; P L Green; M D Lairmore
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 4.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

5.  Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells.

Authors:  T Ohashi; S Hanabuchi; H Kato; Y Koya; F Takemura; K Hirokawa; T Yoshiki; Y Tanaka; M Fujii; M Kannagi
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 6.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

Review 7.  Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.

Authors:  Michael Bindhu; Amrithraj Nair; Michael D Lairmore
Journal:  Front Biosci       Date:  2004-09-01

Review 8.  Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.

Authors:  Inbal Azran; Yana Schavinsky-Khrapunsky; Mordechai Aboud
Journal:  Retrovirology       Date:  2004-08-13       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.